Tuesday, October 5, 2021 episode artwork

EPISODE · Oct 5, 2021 · 6 MIN

Tuesday, October 5, 2021

from The Gist Healthcare Podcast

Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels. Hosted on Acast. See acast.com/privacy for more information.

Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels. Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Tuesday, October 5, 2021

0:00 6:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 6 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on October 5, 2021.

What is this episode about?

Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels. Hosted on Acast. See...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!